does glp-1 cause gastroparesis June Blog Post: T2DM Management complicated by Diabetes and Gastroparesis: New Concepts

Typical PA requirements include: Confirmed diagnosis of type 2 diabetes or obesity Documented BMI (often 30 or 27 with comorbidities) Failed trials of other medications Lifestyle modification attempts Recent A1C lab values (for diabetes) Documentation Must Include Height and weight with calculated BMI Diagnosis supporting medical necessity Treatment plan Follow-up and monitoring plan Compliance & Audit Risk GLP-1 medications are a high-risk audit target due to: Rapid growth in utilization High drug cost Off-label prescribing Weight-loss demand Common audit issues: Incorrect diagnosis codes Missing BMI documentation Lack of medical necessity Billing weight-loss drugs to Medicare Inappropriate use of unclassified J-codes Medicare Coverage Rules Medicare Part D generally does not cover weight-loss drugs , even if FDA-approved for obesity

We will cover the following causes in detail: slowed digestive motility, reduced food intake, low fiber consumption, dehydration, electrolyte imbalance, and physical inactivity

Bruising after semaglutide shots is a common concern for patients using this glucagon-like peptide-1 (GLP-1) receptor agonist for type 2 diabetes or chronic weight management

These observations also elucidate the complex neurobiology of food cravings

Free Forever

23 This need for injection can limit patient use and may also restrict the possibility of combining these drugs in fixed-dose treatments with other therapies for cardio-metabolic conditions